Regencell Bioscience Holdings Limited
Index- P/E- EPS (ttm)-0.11 Insider Own88.52% Shs Outstand14.07M Perf Week-30.40%
Market Cap408.03M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float1.44M Perf Month0.00%
Income-1.30M PEG- EPS next Q- Inst Own0.20% Short Float0.92% Perf Quarter-3.46%
Sales- P/S- EPS this Y-65.80% Inst Trans85.87% Short Ratio0.62 Perf Half Y10.22%
Book/sh-0.40 P/B- EPS next Y- ROA- Target Price- Perf Year-
Cash/sh0.01 P/C4080.30 EPS next 5Y- ROE- 52W Range6.00 - 59.00 Perf YTD-8.95%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-50.85% Beta-
Dividend %- Quick Ratio0.00 Sales past 5Y- Gross Margin- 52W Low383.33% ATR3.18
Employees13 Current Ratio0.00 Sales Q/Q- Oper. Margin- RSI (14)37.77 Volatility10.83% 10.00%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.05 Prev Close28.98
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume21.37K Price29.00
Recom- SMA20-23.65% SMA50-1.52% SMA2005.73% Volume1,183 Change0.07%
Jun-20-22 05:27AM  
May-24-22 05:46AM  
May-18-22 08:05AM  
May-16-22 08:56AM  
Apr-14-22 10:03AM  
Apr-07-22 06:09AM  
Mar-01-22 08:30AM  
Feb-17-22 11:40AM  
Feb-16-22 08:42PM  
Dec-13-21 08:35AM  
Nov-22-21 08:15AM  
Nov-02-21 04:00AM  
Oct-19-21 11:44AM  
Sep-10-21 06:18AM  
Sep-02-21 08:00AM  
Aug-20-21 08:00AM  
Aug-05-21 08:00AM  
Jul-20-21 04:05PM  
Jul-16-21 11:43AM  
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.